Form 8-K - Current report:
SEC Accession No. 0001193125-22-166235
Filing Date
2022-06-02
Accepted
2022-06-02 16:16:05
Documents
12
Period of Report
2022-06-01
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d368064d8k.htm   iXBRL 8-K 30017
  Complete submission text file 0001193125-22-166235.txt   155196

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA inab-20220601.xsd EX-101.SCH 2842
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE inab-20220601_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inab-20220601_pre.xml EX-101.PRE 11698
6 EXTRACTED XBRL INSTANCE DOCUMENT d368064d8k_htm.xml XML 3453
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

EIN.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39692 | Film No.: 22991005
SIC: 2836 Biological Products, (No Diagnostic Substances)